The quarter reflected steady revenue growth but underscored challenges in profit conversion, as seen in declining operating ...

Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

Sales: The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and ...

Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results topping the market’s revenue expectations, with sales ...

Today, Benzinga's options scanner identified 8 options transactions for DexCom. This is an unusual occurrence. The sentiment ...

An Apple Watch, which integrates easily into the Dexcom CGM ecosystem ... Until then, if you need a primer on continuous glucose monitoring, we’re happy to oblige.

Over the past decade, the rising cost of insulin epitomized the broader systemic issue of higher healthcare out-of-pocket ...

DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Living with Type 1 diabetes is a numbers game. There’s not a moment in the day free from the burden of tracking your blood ...

DexCom projects 2025 revenue of $4.6 billion, representing 14% growth. This forecast assumes strong demand for CGM systems, expanded reimbursement coverage, and a second-half launch of a 15-day G7 ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...